Lewis 29 - Upper Respiratory Problems Flashcards

(52 cards)

1
Q

MOA/Class

diphenhydramine, hydroxyzine – 1st generation
cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra) – 2nd generation

A

Block histamine from binding to H1 histamine receptors on basophils and mast cells (thus preventing the release of additional histamine and other inflammatory mediators).

Antihistamine

Tucker 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Side effects

diphenhydramine, hydroxyzine – 1st generation
cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra) – 2nd generation

A

Anticholinergic effects
Drowsiness (1st generation drugs) especially when combined with other CNS depressants; also prolonged QT interval and urinary retention

Tucker 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nursing Considerations

diphenhydramine, hydroxyzine – 1st generation
cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra) – 2nd generation

A

Stop several days before allergy testing. Manage anticholinergic (drying) effects. Most beneficial when given early in histamine-induced reactions.

Tucker 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indications

diphenhydramine, hydroxyzine – 1st generation
cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra) – 2nd generation

A

Allergic rhinitis, adjuct for anaphylaxis, pruritis, motion sickness, *insomnia (use with caution especially in older adults).

Tucker 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA/Class

montelukast

A

Leukotrienes are produced in leukocytes such as mast cells. Once released from the mast cell during an inflammatory response, leukotrienes mediate additional responses such as bronchial constriction
LTRAs prevent leukotrienes from attaching to receptors on lymphocytes and alveolar macrophages thus reducing the inflammatory response thus preventing smooth muscle contraction (bronchi), decreasing mucus secretion, decreasing vascular permeability

Leukotriene Receptor Antagonist (LTRA)

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Side Effects

montelukast

A

Headache, nausea, diarrhea, cough, elevated LFTs, myalgia, neuropsychiatric events

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nursing Considerations

montelukast

A

Tablets contain lactose (monitor patients for lactose intolerance)
Maintenance therapy
Safe for young children (used in ages 2 years and older)

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indications

montelukast

A

Asthma, seasonal allergic rhinitis

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA/Class

pseudoephedrine, phenylephrine

A

pseudoephedrine (alpha-adrenergic); phenylephrine (alpha- and beta-adrenergic)
Vasoconstriction of blood vessels specifically in the nasal passages and sinuses

Adrenergic - Oral decongestant

Tucker 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side Effects

pseudoephedrine, phenylephrine

A

HTN, nervousness, insomia, vision changes/light sensitivity

Tucker 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nursing Considerations

pseudoephedrine, phenylephrine

A

May worsen narrow angle glaucoma.
Use cautiously with other cardiac or CNS medications.

Tucker 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications

pseudoephedrine, phenylephrine

A

Cold/allergy congestion, otitis media, hypotension, pupil dilation

Tucker 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA/Class

cromolyn sodium

A

Suppresses release of histamine and other inflammatory mediators from mast cells

Mast-Cell Stabilizer

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Side Effects

cromolyn sodium

A

Nasal irritation (when administered as a nasal spray)

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nursing Considerations

cromolyn sodium

A

Usually started 1 week before pollen season starts and use throughout pollen season

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications

cromolyn sodium

A

Allergic conditions (usually reserved for those whose symptoms are not managed well with other therapies).

Tucker 55

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA/Class

fluticasone

Intranasal

A

Steroids stabilize leukocytes (WBCs) preventing the release of intracellular chemical/inflammatory mediators
Restore/increase bronchial responsiveness to beta-adrenergic receptor stimulation

Glucocorticoid/steroid

Tucker 36, 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Side Effects

fluticasone

Intranasal

A

Localized dryness; limited/few systemic adverse effects

Tucker 36, 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nursing Considerations

fluticasone

Intranasal

A

May be used prophylactically.

Tucker 36, 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Indications

fluticasone

Intranasal

A

Allergic rhinitis, inflammation after removal of nasal polyps

Tucker 36, 54

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA/Class

ipratropium

Intranasal

A

Decreased secretions due to anti-SLUDGE effects

Anticholinergic

Tucker 33

22
Q

Side Effects

ipratropium

Intranasal

A

Localized dryness; limited/few systemic adverse effects

Tucker 33

23
Q

Nursing Considerations

ipratropium

Intranasal

A

May be used prophylactically.

Tucker 33

24
Q

Indications

ipratropium

Intranasal

A

Allergic rhinitis

Tucker 33

25
# MOA/Class oxymetolazine (Afrin); phenylephrine | Intranasal
Vasoconstriction of blood vessels specifically in the nasal passages and sinuses | Adrenergic/topical decongestant ## Footnote Tucker 54
26
# Side Effects oxymetolazine (Afrin); phenylephrine | Intranasal
Nasal dryness ## Footnote Tucker 54
27
# Nursing Considerations oxymetolazine (Afrin); phenylephrine | Intranasal
Use for more than 3-5 days can result in rebound congestion; Do not use for patients with HTN or other conditions that may be worsened by systemic absorption (glaucoma, coronary disease, etc.) ## Footnote Tucker 54
28
# Indications oxymetolazine (Afrin); phenylephrine | Intranasal
Nasal congestion ## Footnote Tucker 54
29
# MOA/Class dextromethorphan; benzonatate, codeine
Dextromethorphan – suppresses cough reflex in CNS Benzonatate – numbs stretch receptors in the respiratory tract, thus prevent stimulation of the cough center Codeine – CNS depressant/opioid – suppress cough reflex in CNS; drying effect | Antitussive ## Footnote Tucker 54
30
# Side Effects dextromethorphan; benzonatate, codeine
Drowsiness, dry mouth , dizzy/lightheadedness ## Footnote Tucker 54
31
# Nursing Considerations dextromethorphan; benzonatate, codeine
Consider benefit of expectorant for productive cough instead of cough suppressant Encourage other measures to help cough - humidity, cool temperatures, fluids, topical lozenges, etc. ## Footnote Tucker 54
32
# Indications dextromethorphan; benzonatate, codeine
Dry cough; persistent cough ## Footnote Tucker 54
33
# MOA/Class echinacea
Thought to be immunostimulant | Herbal ## Footnote Tucker 60
34
# Side Effects echinacea
N/V, dizziness, headache ## Footnote Tucker 60
35
# Nursing Considerations echinacea
Consider potential for drug interactions ## Footnote Tucker 60
36
# Indications echinacea
Colds, flu, viral infections ## Footnote Tucker 60
37
# MOA/Class acetaminophen
Acts on the hypothalamus to decrease fever. Inhibits prostaglandin synthesis. | Analgesic/antipyretic ## Footnote Tucker 16
38
# Side Effects acetaminophen
Generally well-tolerated. Hepatotoxicity. ## Footnote Tucker 16
39
# Nursing Considerations acetaminophen
Maximum dose 4g/day for most patients; May be reduced to 2-3 g/day for patients with hepatic impairment. Combined hepatotoxic effects with alcohol. Be aware of OTC drugs that may also contain acetaminophen (daily limit). Acetylcystine may be used for acute hepatotoxicity/overdose. May alter metabolism of drugs requiring liver biotransformation. ## Footnote Tucker 16
40
# Indications acetaminophen
Mild pain and fever ## Footnote Tucker 16
41
# MOA/Class oseltamivir (Tamiflu)
Prevents synthesis of viral DNA/release of viral particles. | Antiviral ## Footnote Tucker 10
42
# Side Effects oseltamivir (Tamiflu)
Generally well-tolerated. ## Footnote Tucker 10
43
# Nursing Considerations oseltamivir (Tamiflu)
Most effective when started within 48 hours of symptom onset. ## Footnote Tucker 10
44
# Indications oseltamivir (Tamiflu)
Influenza (treatment or prophylaxis) ## Footnote Tucker 10
45
# MOA/Class penicillin; amoxicillin; amoxicillin/clavulanic acid (Augmentin)
Binds to bacterial cell wall causing cell death. | PCN/Beta-lactam antibiotic ## Footnote Tucker 09
46
# Side Effects penicillin; amoxicillin; amoxicillin/clavulanic acid (Augmentin)
Urticaria, pruritis, angioedema, SJS, GI upset, *c. diff* ## Footnote Tucker 09
47
# Nursing Considerations penicillin; amoxicillin; amoxicillin/clavulanic acid (Augmentin)
Potential cross-allergy with cephalosporins; monitor for hypersensitivity ## Footnote Tucker 09
48
# Indications penicillin; amoxicillin; amoxicillin/clavulanic acid (Augmentin)
Bacterial infections - group A strep infections ## Footnote Tucker 09
49
# MOA/Class nystatin
Disrupts fungal cell membrane altering cell metabolism ## Footnote Tucker 11
50
# Side Effects nystatin
Generally well-tolerated ## Footnote Tucker 11
51
# Nursing Considerations nystatin
May be administered as swish-and-swallow or swish-and-spit ## Footnote Tucker 11
52
# Indications nystatin
Oral candida infections ## Footnote Tucker 11